Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H RINDERKNECHT

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Clinical Immunology and Immunopathology|December 1, 1979
Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokineR H Weisbart, D W Golde, L Spolter, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loadingTieying Hou, Cornelia H Rinderknecht, Andreas V Hadjinicolaou, et al.
Biochimica Et Biophysica Acta|June 24, 1975
Human pancreatic carboxypeptidase B. I. Isolation, purification, and characterization of fraction IIM C Geokas, C Largman, J W Brodrick, et al.
Expert Opinion on Drug Discovery|February 26, 2024
Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunitiesCornelia H Rinderknecht, Miaoran Ning, Connie Wu, et al.
Clinical Biochemistry|October 1, 1971
Clinical evaluation of an a-amylase assay with insoluble starch labeled with Remazolbrilliant Blue (amylopectin-azure)H Rinderknecht, E P Marbach, C R Carmack, et al.
Journal of Pharmaceutical Sciences|May 5, 2025
Investigation of the suitability of utilizing plasma concentration as a surrogate to understand lung exposure of inhaled drug in rats: Different delivery methods of fluticasone propionatePo-Chang Chiang, Cornelia H Rinderknecht, Jia Liu, et al.
International Immunology|June 16, 2010
I-Ag7 is subject to post-translational chaperoning by CLIPCornelia H Rinderknecht, Ning Lu, Oliver Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesisTaejin Yoon, Henriette Macmillan, Sarah E Mortimer, et al.
Immunological Reviews|September 27, 2005
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expressionRobert Busch, Cornelia H Rinderknecht, Sujin Roh, et al.
The Review of Scientific Instruments|October 7, 2011
Changes in CR-39 proton sensitivity due to prolonged exposure to high vacuums relevant to the National Ignition Facility and OMEGAM J-E Manuel, M J Rosenberg, N Sinenian, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Immunology and Immunopathology|December 1, 1979
Neutrophil migration inhibition factor from T lymphocytes (NIF-T): a new lymphokineR H Weisbart, D W Golde, L Spolter, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 19, 2013
Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loadingTieying Hou, Cornelia H Rinderknecht, Andreas V Hadjinicolaou, et al.
Biochimica Et Biophysica Acta|June 24, 1975
Human pancreatic carboxypeptidase B. I. Isolation, purification, and characterization of fraction IIM C Geokas, C Largman, J W Brodrick, et al.
Expert Opinion on Drug Discovery|February 26, 2024
Designing inhaled small molecule drugs for severe respiratory diseases: an overview of the challenges and opportunitiesCornelia H Rinderknecht, Miaoran Ning, Connie Wu, et al.
Clinical Biochemistry|October 1, 1971
Clinical evaluation of an a-amylase assay with insoluble starch labeled with Remazolbrilliant Blue (amylopectin-azure)H Rinderknecht, E P Marbach, C R Carmack, et al.
Journal of Pharmaceutical Sciences|May 5, 2025
Investigation of the suitability of utilizing plasma concentration as a surrogate to understand lung exposure of inhaled drug in rats: Different delivery methods of fluticasone propionatePo-Chang Chiang, Cornelia H Rinderknecht, Jia Liu, et al.
International Immunology|June 16, 2010
I-Ag7 is subject to post-translational chaperoning by CLIPCornelia H Rinderknecht, Ning Lu, Oliver Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2012
Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesisTaejin Yoon, Henriette Macmillan, Sarah E Mortimer, et al.
Immunological Reviews|September 27, 2005
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expressionRobert Busch, Cornelia H Rinderknecht, Sujin Roh, et al.
The Review of Scientific Instruments|October 7, 2011
Changes in CR-39 proton sensitivity due to prolonged exposure to high vacuums relevant to the National Ignition Facility and OMEGAM J-E Manuel, M J Rosenberg, N Sinenian, et al.
Pageof 8